Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence

Expert Rev Gastroenterol Hepatol. 2013 Aug;7(6):493-5. doi: 10.1586/17474124.2013.814884.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticarcinogenic Agents / therapeutic use*
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / genetics
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Incidence
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / genetics
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / prevention & control*
  • Patient Selection
  • Prognosis
  • Risk Assessment
  • Risk Factors

Substances

  • Anticarcinogenic Agents
  • Biomarkers, Tumor
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors